Gene · 55244
Papers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Navigating Drug-Drug Interactions in Clinical Drug Development: A Tutorial. | Clin Transl Sci | 2025 | 40984681 | PubTator, text mining | PubMed |
Frequency of Polymorphisms in SLC47A1 (rs2252281 and rs2289669) and SLC47A2 (rs34834489 and rs12943590) and the Influence of SLC22A1 (rs72552763 and rs622342) on HbA1c Levels in Mexican-Mestizo Patients with DMT2 Treated with Metformin Monotherapy. | Int J Mol Sci | 2025 | 40943569 | PubTator, text mining | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin. | AAPS Open | 2025 | 40881130 | PubTator, text mining | PubMed |
| Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel Disease. | Genes (Basel) | 2025 | 40869955 | PubTator, text mining | PubMed |
| Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications. | Cell Death Discov | 2025 | 40855044 | PubTator, text mining | PubMed |
| Safety and feasibility trial protocol of metformin in infants after perinatal brain injury. | BMJ Paediatr Open | 2025 | 40850908 | PubTator, text mining | PubMed |
| Integrative analysis of polyamine metabolism-related genes in gliomas: implications for prognosis and therapy. | Front Oncol | 2025 | 40761256 | PubTator, text mining | PubMed |
| Protective Effect of Palonosetron against Cisplatin-Induced Cytotoxicity via Decreased Phosphorylation of p38. | Biol Pharm Bull | 2025 | 40738650 | PubTator, text mining | PubMed |
| In vitro transporter substrate properties of previously reported biomarkers for renal OAT1/OAT3-mediated drug-drug interactions. | Biochem Pharmacol | 2025 | 40692107 | PubTator, text mining | PubMed |
| Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins. | Amino Acids | 2025 | 40555835 | PubTator, text mining | PubMed |
| Contributions of pharmacogenetics to personalized precision therapy of diabetes and hypercholesterolemia. | Gac Med Mex | 2025 | 40532247 | PubTator, text mining | PubMed |
| Substrate Specificity of the Organic Cation Transporters MATE1 and MATE2K and Functional Overlap with OCT1 and OCT2. | J Med Chem | 2025 | 40512599 | PubTator, text mining | PubMed |
| Molecular pharmacokinetic mechanism of JBP485 against aristolochic acid I (AAI) -induced nephrotoxicity. | Front Pharmacol | 2025 | 40371353 | PubTator, text mining | PubMed |
| Substrate-specific inhibition of organic cation transporter 1 revealed using a multisubstrate drug cocktail. | Drug Metab Dispos | 2025 | 40319555 | PubTator, text mining | PubMed |
| The Solute Carrier Family 47 Member 1, Transcriptionally Regulated by GATA Binding Protein 6, Inhibits Ferroptosis in Gastric Cancer. | DNA Cell Biol | 2025 | 40295115 | PubTator, text mining | PubMed |
| Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro Data. | Clin Pharmacol Ther | 2025 | 40294080 | PubTator, text mining | PubMed |
| A Novel Protocol for Culturing Polarized Proximal Tubular Epithelial Cells from Kidney Biopsies: Enhancing Platforms for Drug Excretion and Nephrotoxicity Studies. | J Xenobiot | 2025 | 40278157 | PubTator, text mining | PubMed |
| A strategy for evaluating the impact of processing of Chinese meteria medica on meridian tropism: the influence of salt-water processing of phellodendri chinensis cortex on renal transport proteins. | Front Pharmacol | 2025 | 40260384 | PubTator, text mining | PubMed |
| Molecular determinants of neuroprotection in blood-brain interfaces of the cynomolgus monkey. | Front Pharmacol | 2025 | 40144668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55244/papers?page=3